Efficacy & Safety of Symbicort® TURBUHALER® 160/4.5 µg Twice Daily & Pulmicort® TURBUHALER® 200 µg Twice Daily + Theolong® Tablet 200 mg Twice Daily in Japanese Asthmatic Patients

This study has been completed.

Study NCT00252785 Information provided by AstraZeneca

First Received: November 11, 2005 Last Updated: March 16, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	November 2006
Estimated Primary Completion Date:	No date given